The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Matrix Surgical USA sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Matrix Surgical USA is a medical device company that develops, manufactures, and distributes sterile and biocompatible craniofacial implants. The company’s flagship product, Omnipore surgical implants is a high-density polyethylene implant for craniofacial reconstructive and aesthetic surgery. It also offers customized and orbital implant products. The company provides its products to healthcare providers through its distribution network in the Americas, Europe, the Middle East and Africa, and Asia. Matrix Surgical USA is headquartered in Newnan, Georgia, the US.
The key metrics of Matrix Surgical USA related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Matrix Surgical USA is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Matrix Surgical USA.
For a detailed understanding of the performance of Matrix Surgical USA, buy the report here.